Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

605 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models.
Saito Y, Iida-Norita R, Afroj T, Refaat A, Hazama D, Komori S, Ohata S, Takai T, Oduori OS, Kotani T, Funakoshi Y, Koma YI, Murata Y, Yakushijin K, Matsuoka H, Minami H, Yokozaki H, Manz MG, Matozaki T. Saito Y, et al. Among authors: takai t. Front Immunol. 2023 Dec 14;14:1294814. doi: 10.3389/fimmu.2023.1294814. eCollection 2023. Front Immunol. 2023. PMID: 38162643 Free PMC article.
Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis.
Okamoto T, Murata Y, Hasegawa D, Yoshida M, Tanaka D, Ueda T, Hazama D, Oduori OS, Komori S, Takai T, Saito Y, Kotani T, Kosaka Y, Maniwa Y, Matozaki T. Okamoto T, et al. Among authors: takai t. Cancer Sci. 2023 May;114(5):1871-1881. doi: 10.1111/cas.15758. Epub 2023 Feb 27. Cancer Sci. 2023. PMID: 36788737 Free PMC article.
CD47 promotes peripheral T cell survival by preventing dendritic cell-mediated T cell necroptosis.
Komori S, Saito Y, Nishimura T, Respatika D, Endoh H, Yoshida H, Sugihara R, Iida-Norita R, Afroj T, Takai T, Oduori OS, Nitta E, Kotani T, Murata Y, Kaneko Y, Nitta R, Ohnishi H, Matozaki T. Komori S, et al. Among authors: takai t. Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2304943120. doi: 10.1073/pnas.2304943120. Epub 2023 Aug 7. Proc Natl Acad Sci U S A. 2023. PMID: 37549290 Free PMC article.
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Fujimoto S, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: takai t. Int J Clin Oncol. 2025 Jan;30(1):123-133. doi: 10.1007/s10147-024-02649-2. Epub 2024 Oct 28. Int J Clin Oncol. 2025. PMID: 39467994
Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer.
Gui F, Jiang B, Jiang J, He Z, Tsujino T, Takai T, Arai S, Pana C, Köllermann J, Bradshaw GA, Eisert R, Kalocsay M, Fassl A, Balk SP, Kibel AS, Jia L. Gui F, et al. Among authors: takai t. bioRxiv [Preprint]. 2024 Nov 7:2024.07.09.602803. doi: 10.1101/2024.07.09.602803. bioRxiv. 2024. PMID: 39026842 Free PMC article. Preprint.
Hidrocystoma-like tumours with RET or ALK fusion: a study of four cases.
Goto K, Kervarrec T, Tallet A, Macagno N, Pissaloux D, Fouchardière A, Battistella M, Kajiwara M, Nagao T, Fujita I, Kajimoto K, Goto H, Matsumura H, Takai T. Goto K, et al. Among authors: takai t. Pathology. 2024 Oct;56(6):865-873. doi: 10.1016/j.pathol.2024.04.008. Epub 2024 Jun 26. Pathology. 2024. PMID: 39009490
605 results